跳至主要内容
临床试验/NCT03031275
NCT03031275已完成不适用

Long-term Follow Up of Adult Patients Treated With Extracorporeal Membrane Oxygenation for Respiratory Failure

Karolinska University Hospital1 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2014年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
31
试验地点
1
主要终点
Number of Participants With Abnormal Lungs radiographic findings assessed by high-resolution CT scan

研究概览

简要总结

Follow-up after treatment with Extracorporeal Membrane Oxygenation (ECMO) at the ECMO Center Karolinska.

Patients: adult survivors treated with ECMO for severe refractory respiratory failure at least 5 years earlier.

Investigations: brain and pulmonary radiographic morphology, cognitive testing, pulmonary function testing, exercise tolerance, quality of life and mood disorder screening.

详细描述

All adult patients treated at the ECMO Center Karolinska between 1995 and July 2009 were screened for eligibility in January 2014. Patients living abroad (including non-Swedish citizens), patients treated for non-respiratory conditions, diseased patients and patients with a known pre-ECMO mental handicap were excluded.

Eligible patients were contacted, and patients who agreed to participate gave their written informed consent. All studied patients underwent the same study protocol during a day at the hospital, including a clinical interview, MRI scan of the brain, HRCT scan of the thorax, pulmonary function testing, neuropsychological examination, walking test, self assessment questionnaires for quality of life, anxiety, depression and post-traumatic stress.

Patient charts were reviewed for relevant clinical information, including age, gender, ECMO mode (venovenous or venoarterial), time in hospital, on ECMO, non-ECMO ICU and on mechanical ventilation; preexisting diseases, blood gas values and ventilator settings before initiation of ECMO treatment. Hand written clinical data from the patients´ charts from every hour with ECMO treatment was reviewed for ventilator settings, lung volumes, mean arterial pressure, hemoglobin, lactate and oxygenation parameters during an observation period, which was defined as the first 10 days on ECMO (or the entire treatment period if shorter than 10 days). This information was added to a digital database for the purpose of this study.

At the time of ECMO treatment, arterial hemoglobin oxygen saturation was measured by peripheral pulse oximetry from the right ear, finger or nose. Venous preoxygenator lactate and venous saturation values were used as indicators of sufficient (lactate < 2 mmol l-1 , SvO2 ≥ 70%) or insufficient tissue perfusion.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Other
盲法
Single (Investigator)

盲法说明

All investigators (radiologist, neuropsychologist, physiotherapist) were masked from all patient details other than the fact that they were treated with ECMO (ie did not know when the patient was treated, for what condition, if any side effects were seen and so on).

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Adult patients treated with ECMO at the ECMO Center Karolinska 1995 - July 2009

排除标准

  • •Diseased patients
  • •Patients living abroad (including non-Swedish citizens)
  • •Patients treated for non-respiratory conditions
  • •Patients with a known pre-ECMO mental handicap

结局指标

主要结局

Number of Participants With Abnormal Lungs radiographic findings assessed by high-resolution CT scan

时间窗: 5-17 years after treatment

Non-contrast spiral scan. A series for grading of pulmonary changes was reconstructed, using a high spatial resolution reconstruction algorithm with 1 mm-width, overlapping slices. Four patterns were mapped: reticular, ground-glass opacification, consolidation and decreased attenuation.

Number of participants with signs of post-traumatic stress assessed by the Trauma Screening Questionnaire

时间窗: 5-17 years after treatment

Number of Participants With Abnormal Pulmonary function

时间窗: 5-17 years after treatment

Static and dynamic spirometry. Measured results as % of the expected normal values were presented.

Number of participants with abnormal cognitive functioning assessed by the Wechsler Adult Intelligence Scale and memory tests

时间窗: 5-17 years after treatment

Wechsler Adult Intelligence Scale, 4th ed, Rey Auditory Verbal Learning Test (learning trials 1 to 5 and delayed recall), immediate recall from the Rey Complex Figure and Logical Memory I and II from Wechsler Memory Scale, 3rd ed.

Number of participants with abnormal brain imaging assessed by magnetic resonance imaging

时间窗: 5-17 years after treatment

Sagittal and axial T1- and T2-weighted images, and coronal T2-weighted and T2-weighted fluid attenuated inversion recovery (FLAIR) images. Slice thickness 4 mm. Presence of hypoxic or anoxic damage, infarctions, hemorrhages, and contusion damage were described.

Number of participants with signs of a reduced health related quality-of-life, assessed by the Short Form-36

时间窗: 5-17 years after treatment

Number of participants with signs of a reduced Health related quality-of-life, assessed by the S:t George´s Respiratory Questionnaire

时间窗: 5-17 years after treatment

Number of participants with signs of a reduced exercise tolerance

时间窗: 5-17 years after treatment

6-minute walking test

Number of participants with signs of anxiety and depression assessed by the Hospital and Anxiety Depression Scale

时间窗: 5-17 years after treatment

次要结局

未报告次要终点

研究者

发起方
Karolinska University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Bernhard Holzgraefe

MD, PhD

Karolinska University Hospital

研究点 (1)

Loading locations...

相似试验

Long-term Follow Up of Adult Patients Treated With... | 临床试验